Suppr超能文献

含白喉毒素A片段的融合脂质体在癌症治疗中的应用。

Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy.

作者信息

Mizuguchi H, Nakanishi M, Nakanishi T, Nakagawa T, Nakagawa S, Mayumi T

机构信息

Faculty of Pharmaceutical Science, Osaka University, Japan.

出版信息

Br J Cancer. 1996 Feb;73(4):472-6. doi: 10.1038/bjc.1996.83.

Abstract

Previously we reported that fusogenic liposomes, prepared by fusing simple liposomes with Sendai virus particles, could introduce their contents directly and efficiently into the cytoplasm. In this study, we examined the anti-tumour activity of fusogenic liposomes containing fragment A of diphtheria toxin (DTA). Fusogenic liposomes containing DTA showed high cytotoxicity against sarcoma-180 (S-180) cells in vitro. When these liposomes were administered into the abdominal cavity of ddY mice carrying S-180, tumour cells completely disappeared in four of six tumour-bearing mice without decrease in body weight. Neither simple liposomes containing DTA nor empty fusogenic liposomes had any effect on tumour suppression. We conclude that fusogenic liposomes containing DTA are new and potentially effective tools for the treatment of ascites tumours without any severe side-effects.

摘要

此前我们报道过,通过将简单脂质体与仙台病毒颗粒融合制备的融合脂质体能够直接且高效地将其内容物导入细胞质。在本研究中,我们检测了含有白喉毒素A片段(DTA)的融合脂质体的抗肿瘤活性。含有DTA的融合脂质体在体外对肉瘤-180(S-180)细胞表现出高细胞毒性。当将这些脂质体注入携带S-180的ddY小鼠腹腔时,六只荷瘤小鼠中有四只的肿瘤细胞完全消失,且体重未减轻。含有DTA的简单脂质体和空的融合脂质体对肿瘤抑制均无任何作用。我们得出结论,含有DTA的融合脂质体是治疗腹水肿瘤的新型且潜在有效的工具,且无任何严重副作用。

相似文献

本文引用的文献

2
Specific purification of elongation factor 2 and isolation of its antibody.延伸因子2的特异性纯化及其抗体的分离。
Biochem Biophys Res Commun. 1986 Jan 29;134(2):1015-21. doi: 10.1016/s0006-291x(86)80522-8.
5
Diphtheria toxin: quantification and assay.白喉毒素:定量与测定
Methods Enzymol. 1988;165:218-25. doi: 10.1016/s0076-6879(88)65034-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验